These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2024973)

  • 1. Bioavailability and pharmacokinetics of ofloxacin in healthy volunteers.
    Yuk JH; Nightingale CH; Quintiliani R; Sweeney KR
    Antimicrob Agents Chemother; 1991 Feb; 35(2):384-6. PubMed ID: 2024973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioequivalence of oral and intravenous ofloxacin after multiple-dose administration to healthy male volunteers.
    Flor SC; Rogge MC; Chow AT
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1468-72. PubMed ID: 8363378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever.
    Bethell DB; Day NP; Dung NM; McMullin C; Loan HT; Tam DT; Minh LT; Linh NT; Dung NQ; Vinh H; MacGowan AP; White LO; White NJ
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2167-72. PubMed ID: 8878600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses.
    Chien SC; Rogge MC; Gisclon LG; Curtin C; Wong F; Natarajan J; Williams RR; Fowler CL; Cheung WK; Chow AT
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2256-60. PubMed ID: 9333057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability and pharmacokinetics of oral ofloxacin formulations in normal subjects.
    Stein GE; LeBel M; Flor SC; Zinny M
    Curr Med Res Opin; 1991; 12(8):479-84. PubMed ID: 1764952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics of intravenous ofloxacin and ciprofloxacin.
    Lode H; Höffken G; Olschewski P; Sievers B; Kirch A; Borner K; Koeppe P
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():73-9. PubMed ID: 3182465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of ofloxacin in broiler chicken.
    Kalaiselvi L; Sriranjani D; Ramesh S; Sriram P; Mathuram LN
    J Vet Pharmacol Ther; 2006 Jun; 29(3):185-9. PubMed ID: 16669862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of ofloxacin. An overview.
    Flor S
    Am J Med; 1989 Dec; 87(6C):24S-30S. PubMed ID: 2603892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and pharmacokinetics of multiple doses of intravenous ofloxacin in healthy volunteers.
    Guay DR; Opsahl JA; McMahon FG; Vargas R; Matzke GR; Flor S
    Antimicrob Agents Chemother; 1992 Feb; 36(2):308-12. PubMed ID: 1605596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bioavailability of ofloxacin from several formulations.
    Flor S; Beals B
    Curr Med Res Opin; 1991; 12(5):282-6. PubMed ID: 2004540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ofloxacin after single and multiple intravenous infusions in healthy subjects.
    Farinotti R; Trouvin JH; Bocquet V; Vermerie N; Carbon C
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1590-2. PubMed ID: 3190187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and relative bioavailability of ofloxacin tablets in 12 healthy volunteers.
    Diao Y; Li L; Zhou GH; Cheng Y
    Zhongguo Yao Li Xue Bao; 1992 Mar; 13(2):110-2. PubMed ID: 1598824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ofloxacin through three administration routes.
    Zhuo HT; Lu JZ; Xia XR; Ling SS
    Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):411-3. PubMed ID: 7717063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of gender on the pharmacokinetics of ofloxacin.
    Sowinski KM; Abel SR; Clark WR; Mueller BA
    Pharmacotherapy; 1999 Apr; 19(4):442-6. PubMed ID: 10212016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sucralfate on absorption of norfloxacin and ofloxacin.
    Lehto P; Kivistö KT
    Antimicrob Agents Chemother; 1994 Feb; 38(2):248-51. PubMed ID: 8192452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence study of a fixed dose combination of nitazoxanide and ofloxacin in Indian healthy volunteers.
    Agarwal S; Solomon WD; Gowda KV; Selvan PS; Ghosh D; Sarkar AK; Chattaraj TK; Pal TK
    Arzneimittelforschung; 2007; 57(10):679-83. PubMed ID: 18074762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ofloxacin in elderly patients and in healthy young subjects.
    Molinaro M; Villani P; Regazzi MB; Rondanelli R; Doveri G
    Eur J Clin Pharmacol; 1992; 43(1):105-7. PubMed ID: 1505603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aqueous humor penetration of ofloxacin given by various routes.
    von Gunten S; Lew D; Paccolat F; Vaudaux P; Brazitikos PD; Leuenberger PM
    Am J Ophthalmol; 1994 Jan; 117(1):87-9. PubMed ID: 8291598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and pharmacokinetics of single dose intravenous ofloxacin in healthy volunteers.
    Guay D; Tack K; Flor S
    Int J Clin Pharmacol Res; 1991; 11(5):203-9. PubMed ID: 1814841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of effect of Chinese medicines on bioavailability of ofloxacin in healthy volunteers.
    Hasegawa T; Yamaki K; Nadai M; Muraoka I; Wang L; Takagi K; Nabeshima T
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):57-61. PubMed ID: 8004359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.